AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough leukemia cases
Disease control CompletedThis study tested whether adding the drug lenalidomide to a standard chemotherapy regimen (MEC) could help adults with acute myeloid leukemia (AML) that had come back or not responded to prior treatment. 41 patients took part. The main goal was to see how many achieved complete r…
Matched conditions: AML
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
First human tests of ZE46-0134 drug completed safely
Knowledge-focused CompletedThis early-stage study tested a new drug called ZE46-0134 in 112 healthy volunteers to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. The study is now complete, and the results will help decide if further testing …
Matched conditions: AML
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC